BioElectronics Corporation's Chairman Updates Investors
16 oct. 2024 08h45 HE
|
BioElectronics Corporation
Outlines Sales Activities, Clinical Trials, and a Potential Legal Action Against MundiPharma FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/...
BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly
07 oct. 2019 12h37 HE
|
BioElectronics Corporation
FREDERICK, MD, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corp. (OTCPK: BIEL) is sad to announce that its founder and CEO, Andrew J. Whelan, died suddenly last night at his...
Update: BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
02 oct. 2019 21h29 HE
|
BioElectronics Corporation
FREDERICK, MD, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
02 oct. 2019 09h44 HE
|
BioElectronics Corporation
FREDERICK, MD, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
01 juil. 2019 08h57 HE
|
BioElectronics Corporation
FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Pain
03 juin 2019 09h31 HE
|
BioElectronics Corporation
FREDERICK, MD, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain
22 mai 2019 10h43 HE
|
BioElectronics Corporation
FREDERICK, MD, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today...
BioElectronics Announces Back Pain Clinical Study with Leading Australian Pain Center
08 mars 2019 10h36 HE
|
BioElectronics Corporation
Pulsed Shortwave Neuromodulation Therapy (ActiPatch®) Study in Chronic Lower Back Pain FREDERICK, MD, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC...
BioElectronics Announces FDA Market Clearance Update
27 nov. 2018 09h31 HE
|
BioElectronics Corporation
FREDERICK, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC Pink: BIEL), the maker of non-invasive electroceutical devices, announced that the U.S. Food...
BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program
13 août 2018 07h30 HE
|
BioElectronics Corporation
FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...